Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us
  • Log out of your HL account

ConvaTec Group Plc (CTEC) Ord GBP0.1

Sell:210.50p Buy:210.80p 0 Change: 5.20p (2.41%)
FTSE 250:2.56%
Market closed |  Prices as at close on 24 February 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:210.50p
Buy:210.80p
Change: 5.20p (2.41%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 24 February 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:210.50p
Buy:210.80p
Change: 5.20p (2.41%)
Market closed |  Prices as at close on 24 February 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ConvaTec Group PLC is a United Kingdom-based medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets.

Contact details

Address:
Fl 7, 3 Forbury Place, 23 Forbury Road
READING
RG1 3JH
United Kingdom
Telephone:
+ (0)
Website:
https://www.convatecgroup.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 30 October 2019 30/10/19
Interim dividend payment date 17 October 2019 17/10/19
Interim ex-dividend date 05 September 2019 05/09/19
Interim results 01 August 2019 01/08/19
Final dividend payment date 16 May 2019 16/05/19
AGM 09 May 2019 09/05/19
Trading Announcement 03 May 2019 03/05/19
Final ex-dividend date 04 April 2019 04/04/19
Annual report 27 February 2019 27/02/19

General stock information

EPIC:
CTEC
ISIN:
GB00BD3VFW73
Market cap:
£4.18 billion
Shares in issue:
1.98 billion
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE 250,FTSE 350,FTSE All Share

Key personnel

  • John McAdam
    Chairman of the Board
  • Karim Bitar
    Chief Executive Officer, Director
  • Frank Schulkes
    Chief Financial Officer, Executive Director
  • Stephan Bonnelycke
    President - Ostomy Care
  • Kjersti Grimsrud
    President - EMEA
  • John Lindskog
    President - B2B and Infusion Devices
  • David Shepherda
    President - Advanced Wound Care
  • Sean McGrath
    Executive Vice President - Global Human Resources
  • Donal Balfe
    Executive Vice President - Global Operations
  • Supratim Bose
    Executive Vice President and President, APAC

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.